Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1971 Sep;47(551):599–604. doi: 10.1136/pgmj.47.551.599

Mitral valve disease, systemic embolism and anticoagulants*

H A Fleming, Sheila M Bailey
PMCID: PMC2467310  PMID: 5098918

Abstract

Over a period of 9½ years patients in East Anglia with mitral valve disease not requiring immediate surgery have been followed.

There has been a high incidence of systemic embolism before the patients are referred.

Long-term treatment with anticoagulants appears to offer a good degree of protection to these patients and, provided the control of the treatment is good, the risks arising from it are small and less than the risks of embolism.

Full text

PDF
599

Images in this article

603Fig. 2
on p.603

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CASELLA L., ABELMANN W. H., ELLIS L. B. PATIENTS WITH MITRAL STENOSIS AND SYSTEMIC EMBOLI; HEMODYNAMIC AND CLINICAL OBSERVATIONS. Arch Intern Med. 1964 Dec;114:773–781. doi: 10.1001/archinte.1964.03860120085008. [DOI] [PubMed] [Google Scholar]
  2. Coulshed N., Epstein E. J., McKendrick C. S., Galloway R. W., Walker E. Systemic embolism in mitral valve disease. Br Heart J. 1970 Jan;32(1):26–34. doi: 10.1136/hrt.32.1.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. FLEMING H. A., WOOD P. The myocardial factor in mitral valve disease. Br Heart J. 1959 Jan;21(1):117–122. doi: 10.1136/hrt.21.1.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HUTCHINSON E. C., STOCK J. P. PAROXYSMAL CEREBRAL ISCHAEMIA IN RHEUMATIC HEART-DISEASE. Lancet. 1963 Sep 28;2(7309):653–656. doi: 10.1016/s0140-6736(63)90451-3. [DOI] [PubMed] [Google Scholar]
  5. LILLICRAP D., PIESOWICZ A. MITRAL STENOSIS AND SYSTEMIC EMBOLI. Br Med J. 1964 Nov 7;2(5418):1169–1171. doi: 10.1136/bmj.2.5418.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. OBEYESEKERE H. I., DULAKE M., DEMERDASH H., HOLLISTER R. SYSTEMIC HYPERTENSION AND MITRAL VALVE DISEASE. Br Med J. 1965 Aug 21;2(5459):441–445. doi: 10.1136/bmj.2.5459.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SALT H. B., WOLFF O. H., LLOYD J. K., FOSBROOKE A. S., CAMERON A. H., HUBBLE D. V. On having no beta-lipoprotein. A syndrome comprising a-beta-lipoproteinaemia, acanthocytosis, and steatorrhoea. Lancet. 1960 Aug 13;2(7146):325–329. doi: 10.1016/s0140-6736(60)91478-1. [DOI] [PubMed] [Google Scholar]
  8. SOMERVILLE W., CHAMBERS R. J. SYSTEMIC EMBOLISM IN MITRAL STENOSIS: RELATION TO THE SIZE OF THE LEFT ATRIAL APPENDIX. Br Med J. 1964 Nov 7;2(5418):1167–1169. doi: 10.1136/bmj.2.5418.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. SZEKELY P. SYSTEMIC EMBOLISM AND ANTICOAGULANT PROPHYLAXIS IN RHEUMATIC HEART DISEASE. Br Med J. 1964 May 9;1(5392):1209–1212. doi: 10.1136/bmj.1.5392.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Swash M., Earl C. J. Transient visual obscurations in chronic rheumatic heart-disease. Lancet. 1970 Aug 15;2(7668):323–326. doi: 10.1016/s0140-6736(70)92869-2. [DOI] [PubMed] [Google Scholar]
  11. WOOD J. C., CONN H. L., Jr Prevention of systemic arterial embolism in chronic rheumatic heart disease by means of protracted anticoagulant therapy. Circulation. 1954 Oct;10(4):517–523. doi: 10.1161/01.cir.10.4.517. [DOI] [PubMed] [Google Scholar]
  12. WOOD P. An appreciation of mitral stenosis. I. Clinical features. Br Med J. 1954 May 8;1(4870):1051–contd. doi: 10.1136/bmj.1.4870.1051. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES